linaclotide IBS-C
Selected indexed studies
- Recent advances in the treatment of irritable bowel syndrome. (Pol Arch Intern Med, 2021) [PMID:34463082]
- Effect of linaclotide in irritable bowel syndrome with constipation (IBS-C): a systematic review and meta-analysis. (Neurogastroenterol Motil, 2014) [PMID:24351035]
- Linaclotide: promising IBS-C efficacy in an era of provisional study endpoints. (Am J Gastroenterol, 2012) [PMID:23160292]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Recent advances in the treatment of irritable bowel syndrome. (2021) pubmed
- Linaclotide. (2026) pubmed
- Effect of linaclotide in irritable bowel syndrome with constipation (IBS-C): a systematic review and meta-analysis. (2014) pubmed
- Linaclotide: promising IBS-C efficacy in an era of provisional study endpoints. (2012) pubmed
- AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation. (2022) pubmed
- The gut microbiota participates in the effect of linaclotide in patients with irritable bowel syndrome with constipation (IBS-C): a multicenter, prospective, pre-post study. (2024) pubmed
- Linaclotide for constipation-predominant IBS. (2013) pubmed
- Efficacy, Safety, and Time to Response of Linaclotide in Patients ≥65 With IBS-C. (2024) pubmed
- Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024. (2025) pubmed
- Effectiveness and tolerability of linaclotide in the treatment of IBS-C in a "real-life" setting: Results from a Portuguese single-center study. (2019) pubmed